Foo-Chee-Guan-David.jpg

Clinical Interests

Heart Rhythm Disorders, Cardiac Implantable Electronic Devices, Preventive Cardiology

Languages

English
Mandarin
About

Adj A/Prof David Foo graduated with MBBS from the University of Melbourne in 1997 and obtained his Membership and Fellowship of Royal College of Physician (United Kingdom) in 2002 and 2012 respectively. He is also a Fellow of the American College of Cardiology, European Society of Cardiology and Heart Rhythm Society. He completed his Electrophysiology and Pacing fellowship at St Vincent's Hospital, Sydney, New South Wales, Australia. He is a Certified Cardiac Device Specialist (CCDS) from the International Board of Heart Rhythm Examiners in 2007 and a Certified Clinical Exercise Specialist from the American College of Sports Medicine in 2011.

He is currently the Clinical Director of the NHG Health Heart Institute. He was also the Head of Department serving his full tenure before stepping down in August 2019. He is an Adj A/Prof with the Yong Loo Lin School of Medicine, National University of Singapore and Lee Kong Chian, School of Medicine. His current interests and research include heart rhythm disorders, cardiac implantable electronic devices and preventive cardiology.

Adj A/Prof Foo has chaired and presented in numerous international and regional conferences. He has also travelled to various parts of Asia to proctor physiological cardiac pacing and resynchronisation therapies.

Publications

1. Physiological pacing: just a lot of buzz or the next paradigm shift in bradycardia pacing?

2. Self-directed cardiac rehabilitation using a novel game-based mobile application paired with sensor: is it feasible?

3. Practical and systematic approach using the steerable catheter and stylet-driven lead to deliver safe and effective left bundle branch area pacing.

4. Tele-ECG collaboration between tertiary and primary care in Singapore: Outcomes and learning over a 6-year period.

5. The Lipid Paradox is present in ST-elevation but not in non-ST-elevation myocardial infarction patients: Insights from the Singapore Myocardial Infarction Registry

6. Impact of time of onset of symptom of ST-segment elevation myocardial infarction on 1-year rehospitalization for heart failure and mortality.

7. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.

8. Association between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention.

9. The curious case of missing heartbeats.

10. Different strokes for different folks.

11. Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors.

12. Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomes.

13. Association of body mass index, metabolic health status and clinical outcomes in acute myocardial infarction patients: a national registry-based study.

14. Result of the left bundle branch area pacing data collection registry, an international multicenter study of conduction system pacing with a Tendril STS 2088 stylet-driven lead.